Form 8-K - Current report:
SEC Accession No. 0001641172-25-025710
Filing Date
2025-08-27
Accepted
2025-08-27 16:30:52
Documents
14
Period of Report
2025-08-21
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 44278
  Complete submission text file 0001641172-25-025710.txt   260935

Data Files

Seq Description Document Type Size
2 XBRL DEFINITION FILE bfrg-20250821_def.xml EX-101.DEF 27003
3 XBRL LABEL FILE bfrg-20250821_lab.xml EX-101.LAB 37236
4 XBRL PRESENTATION FILE bfrg-20250821_pre.xml EX-101.PRE 25624
5 XBRL SCHEMA FILE bfrg-20250821.xsd EX-101.SCH 3733
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5851
Mailing Address 325 ELLINGTON BLVD. UNIT 317 GAITHERSBURG MD 20878
Business Address 325 ELLINGTON BLVD. UNIT 317 GAITHERSBURG MD 20878 3013672055
BullFrog AI Holdings, Inc. (Filer) CIK: 0001829247 (see all company filings)

EIN.: 844786155 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41600 | Film No.: 251265731
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)